S-Bank Fund Management Ltd

Bank

Position in RPRX — Royalty Pharma plc

CIK 2036461 HELSINKI, H9

Position in RPRX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$412,955

-$1,019,525 QoQ

Shares Held

7,365

-75.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#419

of 641 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

S-Bank Fund Management Ltd holds $2,967,528 across 5 Biotechnology names. RPRX ranks #4 (13.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,034	$1,010,348
2	REGN	Regeneron Pharmaceuticals, Inc.	1,012	$631,022
3	ALNY	Alnylam Pharmaceuticals, Inc.	1,844	$555,099
4	RPRX	Royalty Pharma plc This page	7,365	$412,955
5	INCY	Incyte Corp	3,159	$358,104

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$412,955	7,365	-75.3%	Shares	Sole	2026-08-04
2026-03-31	$1,432,480	29,862	-3.6%	Shares	Sole	2026-05-11
2025-12-31	$1,196,758	30,972	-27.9%	Shares	Sole	2026-02-03
2025-09-30	$1,515,240	42,949	-1.3%	Shares	Sole	2025-10-27
2025-06-30	$1,567,593	43,508	—	Shares	Sole	2025-07-29
No filing history on record for this holder in this stock.